The high level of LAPTM4B expression was observed in the breast (2.703 ± 0.1312), ovarian (2.849 ± 0.1501), prostate (2.567 ± 0.1786) and colon (2.688 ± 0.1949) cancer patients compared to healthy controls (0.2546 ± 0.09648) (Fig. 1). This evidence concerns the gene LAPTM4B and cancer.